Results

Looking for more? ProQuest® Dissertations & Theses has additional dissertations and theses.
641 open access dissertations and theses found for:
if(Amyloid)  »   Refine Search
31.
Modulation of BACE1 by a novel sorting nexin in Alzheimer's disease
by Okada, Hirokazu, Ph.D.  Columbia University. 2008: 98 pages; 3299361.
32.
The Pathophysiology of Chronic Stroke Infarcts: What Happens After Brain Tissue Dies?
by Likens, Jacob Andrew, M.S.  The University of Arizona. 2018: 50 pages; 10813111.
33.
The role of histone deacetylase inhibitors in ameliorating memory dysfunction of an Alzheimer's disease mouse model
by Kilgore, Mark, Ph.D.  The University of Alabama at Birmingham. 2013: 136 pages; 3561286.
34.
Role of the Slingshot-Cofilin and RanBP9 Pathways in Alzheimer's Disease Pathogenesis
by Woo, JungA Alexa, Ph.D.  University of South Florida. 2015: 141 pages; 3734762.
35.
Neuroinflammation, Age, and Apoe ϵ4 Affect Aspects of the Autophagy System in Alzheimer's Disease
by Parcon, Paul A., Ph.D.  University of Arkansas for Medical Sciences. 2018: 223 pages; 10815338.
36.
Tetraalkyl and Tetraaryl Bisphosphates: Potential Therapeutics for Treating Alzheimer's Disease
by Takenaka, Show, M.S.  California State University, Long Beach. 2017: 71 pages; 10637597.
37.
Beta-Sheet forming peptides by design: Control of folding and applications
by Takor, Gaius A., Ph.D.  State University of New York at Albany. 2016: 112 pages; 10103515.
38.
Characterization of De Novo Aggregation of Prions and Protein Misfolding Disease Proteins In Yeast
by Arslan, Fatih, Ph.D.  University of Illinois at Chicago. 2014: 276 pages; 3688425.
39.
Impact of Sigma-1 and Sigma-2 Receptor Ligand on Microglial Inflammatory Response
by Bhandari B. C., Suyesha, M.S.  Southern Illinois University at Edwardsville. 2019: 67 pages; 22592438.
40.
Immunotherapy targeting tau pathology-studies in an hTau mouse model
by Forest, Stefanie Karen, Ph.D.  Yeshiva University. 2014: 153 pages; 3535073.
41.
Increased Microglial Survival by NNC 26-9100: A Somatostatin Subtype-4 Selective Agonist
by Walters, Field Delaryn, Jr., M.S.  Southern Illinois University at Edwardsville. 2017: 107 pages; 10275906.
43.
KLC1 deficiency alters APP and tau levels and impairs neuronal development
by Killian, Rhiannon Lynn, Ph.D.  University of California, San Diego. 2011: 138 pages; 3458477.
45.
Novel Somatostatin Receptor Subtype-4 Agonist Mitigates Microglia Inflammatory Activation
by Silwal, Ashok, M.S.  Southern Illinois University at Edwardsville. 2019: 133 pages; 22592201.
46.
Elucidating mother to offspring transmission of chronic wasting disease using a transgenic mouse model
by Willingham, Kassandra, M.S.  Colorado State University. 2016: 97 pages; 10138995.
47.
Exploring a Secretase-Mediated Mechanism of Chlamydia pneumoniae-Induced Alzheimer Disease Pathology
by Al-Atrache, Zein, Ph.D.  University of the Sciences in Philadelphia. 2017: 121 pages; 10904826.
48.
Mitigation of Activated Microglia Associated Pathways by SST4 Agonist SMI-26
by House, Austin, M.S.  Southern Illinois University at Edwardsville. 2020: 93 pages; 27958029.
49.
Atomic Force Microscopy Study of Fibril Formation of Lysozyme
by Mitchell, Myagmarjaw, M.S.  Southern Illinois University at Edwardsville. 2016: 55 pages; 10162146.
50.
Probability of First Recall in Healthy Aging and Preclinical Alzheimer's Disease
by D’Errico, Lisa, M.S.  University of the Sciences in Philadelphia. 2018: 63 pages; 13850246.
51.
Lead Optimization of Triazole-Based Somatostatin Subtype-4 Agonist for the Treatment of Alzheimer’S Disease
by Frare, Rafael F., M.S.  Southern Illinois University at Edwardsville. 2020: 107 pages; 27838098.
52.
Synthesis of [Ru(Phen)2(imPhen)]2+ and the Observation of Its Effects on λ-Phage DNA Via Tapping Mode Atomic Force Microscopy
by Brandenburg, Jake, M.S.  Southern Illinois University at Edwardsville. 2020: 82 pages; 27957788.
53.
Synthesis and Structure-Activity Studies of 3,4,5-Trisubstituted -1,2,4- Triazoles as Somatostatin Subtype -4-Agonists
by Srabony, Khush Nahar, M.S.  Southern Illinois University at Edwardsville. 2020: 114 pages; 28031272.
54.
Comparative Effects of Tolfenamic Acid and Donepezil on Behavior and Tau Pathology Biomarker Levels
by Alharbi, Abdullah G., M.S.  University of Rhode Island. 2019: 54 pages; 27668714.
55.
Using APOE genotypes to identify new biomarkers for Alzheimer's disease risk
by Dumanis, Sonya Benjamina E., Ph.D.  Georgetown University. 2013: 181 pages; 3559756.
56.
Increasing Awareness of Type 3 Diabetes: Present and Future Implications
by Rohrer, Kristen, Ph.D.  University of Bridgeport. 2019: 97 pages; 22589359.
57.
Revisiting Lysozyme and Tri-N-acetylglucosamine Interaction: Preparation and Characterization
by Al-Zuhairi, Wafaa, M.S.  Southern Illinois University at Edwardsville. 2014: 56 pages; 1564060.
59.
Lead Optimization of Triazole-based Somatostatin Subtype-4 Agonists for the Treatment of Alzheimer's Disease
by Minaeian, Mahsa, M.S.  Southern Illinois University at Edwardsville. 2017: 142 pages; 10616070.
60.
Vitamin D Deficiency and Alzheimer's Disease: A Public Information Project
by Ehteshambrojerdi, Mahsa, M.S.  California State University, Long Beach. 2018: 63 pages; 10978432.
31 - 60 of 641 displayed.
« First < Previous |   1    2    3    4    5    6    7    8    9    10   Next >
Copyright © 2020 ProQuest LLC. All rights reserved. Terms and Conditions Privacy Policy Cookie Policy
ProQuest